Mechanisms of angiogenesis in gliomas

被引:123
作者
Kargiotis, O.
Rao, J. S.
Kyritsis, A. P.
机构
[1] Univ Ioannina, Sch Med, Dept Neurol, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Sch Med, Inst Neurosurg, GR-45110 Ioannina, Greece
[3] Univ Illinois, Coll Med, Dept Biomed & Therapeut Sci, Div Canc Biol, Peoria, IL 61656 USA
关键词
angiogenesis; brain tumors; glioblastoma; glioma; VEGF;
D O I
10.1007/s11060-005-9097-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gliomas are the most frequent primary tumors of the central nervous system in adults. Glioblastoma multiforme, the most aggressive form of astrocytic tumors, displays a rapid progression that is accompanied by particular poor prognosis of patients. Intense angiogenesis is a distinguishing pathologic characteristic of these tumors and in fact, glioblastomas are of the most highly vascularized malignant tumors. For this reason, research and therapy strategies have focused on understanding the mechanisms leading to the origin of tumor angiogenic blood vessels in order to develop new approaches that effectively block angiogenesis and cause tumor regression. We discuss here some important features of glioma angiogenesis and we present molecules and factors and their possible functions and interactions that play a role in neovascularization. In spite of the great progress that molecular biology has achieved on investigating tumor angiogenesis, many aspects remain obscure and the complexity of the angiogenic process stands for an obstacle in identifying the exact and complete molecular pathways orchestrating new blood vessels formation, which are necessary for the survival and expansion of these tumors.
引用
收藏
页码:281 / 293
页数:13
相关论文
共 177 条
[51]   Platelet-derived growth factor-b enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment [J].
Guo, P ;
Hu, B ;
Gu, WS ;
Xu, L ;
Wang, DG ;
Huang, HJS ;
Cavenee, WK ;
Cheng, SY .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1083-1093
[52]  
Haskell H, 2003, CLIN CANCER RES, V9, P2157
[53]   Mechanism of action and in vivo role of platelet-derived growth factor [J].
Heldin, CH ;
Westermark, B .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1283-1316
[54]   THE EFFECTS OF TYPE BETA-TRANSFORMING GROWTH-FACTOR ON PROLIFERATION AND EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN A HUMAN GLIOBLASTOMA CELL-LINE [J].
HELSETH, E ;
UNSGAARD, G ;
DALEN, A ;
VIK, R .
JOURNAL OF NEURO-ONCOLOGY, 1988, 6 (03) :269-276
[55]  
HERMANSON M, 1992, CANCER RES, V52, P3213
[56]   ENDOTHELIAL-CELL HYPERPLASIA IN HUMAN GLIOBLASTOMA - COEXPRESSION OF MESSENGER-RNA FOR PLATELET-DERIVED GROWTH-FACTOR (PDGF) B-CHAIN AND PDGF RECEPTOR SUGGESTS AUTOCRINE GROWTH-STIMULATION [J].
HERMANSSON, M ;
NISTER, M ;
BETSHOLTZ, C ;
HELDIN, CH ;
WESTERMARK, B ;
FUNA, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) :7748-7752
[57]   Angiogenic effect of thymidine phosphorylase on macrophages in glioblastoma multiforme [J].
Hirano, H ;
Tanioka, K ;
Yokoyama, S ;
Akiyama, S ;
Kuratsu, J .
JOURNAL OF NEUROSURGERY, 2001, 95 (01) :89-95
[58]  
Hirano H, 1999, Neuro Oncol, V1, P109, DOI 10.1093/neuonc/1.2.109
[59]   Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins [J].
Hiraoka, N ;
Allen, E ;
Apel, IJ ;
Gyetko, MR ;
Weiss, SJ .
CELL, 1998, 95 (03) :365-377
[60]  
Hjelmeland MD, 2004, MOL CANCER THER, V3, P737